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ABSTRACT
Hyperlipidemia results in excessive superoxide anion radicals that are the 
cause of oxidative stress. Phytochemical compounds can reduce oxidative 
stress. The aim of this study was to investigate the correlations between ratio of 
Nrf2/Keap1 and catalase gene expression in livers of hyperlipidemic rats after 
administration of 7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-chromen-4-one. 
Twenty-four Rattus norvegicus rats, aged 8 weeks and weighing an average of 
200 g were randomly divided into 6 groups i.e. Group 1 was normal group (N), 
Group 2 was hyperlipidemic rats (HL), Group 3 was hyperlipidemic rats with 
simvastatin (HL+SV), and Groups 4-6 were hyperlipidemic rats with 7-hydroxy-
2-(4-hydroxy-3-methoxyphenyl)-chromen-4-one doses 10 mg (HL+10), 30 mg 
(HL+30) or 90 mg/200 g BW (HL+90), respectively, administered orally by gavages. 
At the end of the study, the rats were euthanized and the livers were used 
to analyze the ratio of Nrf2/Keap 1 and catalase gene expression. Nrf2/Keap1 
ratio and catalase gene expression between groups were analyzed by Kruskal 
Wallis test. Spearman’s correlation test was used to analyze the correlations 
between Nrf2/Keap1 ratio and catalase gene expression. The administration 
of 3 different doses of 7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-chromen-
4-one on hyperlipidemic rats increased catalase gene expression. There was 
no correlation between ratio Nrf2/Keap1 and catalase gene expression. In 
conclusion, administration of 7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-
chromen-4-one can improve catalase gene expression in hyperlipidemic 
rats. However, there is no correlation between the ratio of Nrf2/Keap1 gene 
expression and the catalase gene expression.
ABSTRAK
Kondisi hiperlipidemia menghasilkan lebih banyak radikal bebas dalam 
bentuk anion superoksida yang menyebabkan stress oksidatif. Komponen 
fitokimia dapat menurunkan stres oksidatif. Penelitian ini bertujuan 
untuk mengetahui hubungan antara ratio Nrf2/Keap1 dan ekspresi gen 
katalase hepar tikus hiperlipidemia yang diberi 7-hidroksi-2-(4-hidroksi-3-
metoksifenil)-kroman-4-on. Dua puluh empat tikus Rattus norvegicus umur 
8 minggu dengan berat sekitar 200 g dibagi secara acak menjadi 6 kelompok 
yaitu Kelompok 1, tikus normal (N), Kelompok 2 tikus hiperlipidemia (HL), 
Kelompok 3 tikus hiperlipidemia yang diberi simvastatin (HL+SV), Kelompok 
4-6 tikus hiperlipidemia yang diberi 7-hidroksi-2-(4-hidroksi-3-metoksifenil)-
kroman-4-on dengan dosis 10 mg (HL+10), 30 mg (HL+30) dan 90 mg (HL+90) 
berturut-turut, secara oral. Pada akhir penelitian, hewan coba didekapitasi 
dan hepar tikus digunakan untuk menganalisis rasio Nrf2/Keap1 dan ekspresi 
gen katalase. Data ratio antar kelompok dianalisis menggunakan Kruskal 
Wallis. Uji korelasi antara ratio Nrf2/Keap1 dan ekspresi gen katalase dengan 
uji Sperman. Pemberian 7-hidroksi-2-(4-hidroksi-3-metoksifenil)-kroman-
4-on dengan 3 peringkat dosis berbeda dapat meningkatkan ekspresi gen 
katalase. Tidak ada korelasi antara ratio Nrf2/Keap1 dan ekspresi gen katalase. 
Dapat disimpulkan bahwa pemberian senyawa 7-hidroksi-2-(4-hidroksi-
3-metoksifenil)-kroman-4-on cenderung dapat memperbaiki ekspresi gen 
katalase pada tikus hiperlipidemia. Namun demikian tidak ada hubungan 
antara ratio ekspresi gen Nrf/2-Keap1 ekspresi gen katalase.
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INTRODUCTION
Hyperlipidemia is one of the risk 
factors for degenerative diseases and 
metabolic syndrome. Several diseases 
related to metabolic syndrome reached 
the top ten list of the world’s deadliest 
diseases during 2015,1 including 
cardiovascular disease, stroke and 
diabetes mellitus.1–4 Hyperlipidemia is a 
lipid metabolism disorder characterized 
by an increase in cholesterol, 
triglycerides or a combination of both 
in the blood. Hyperlipidemia is caused, 
among other reasons, by unhealthy 
lifestyles, lack of physical activity and 
high-fat diet.5 A high-fat diet is linked to 
excessive free radicals, resulting in more 
superoxide anion radicals that are the 
cause of oxidative stress. Oxidative stress 
causes damage to cellular components 
such as carbohydrates, fats, proteins and 
DNA resulting in the formation of new 
free radicals.6 Nuclear factor erythroid 
2-related factor 2 (Nrf2) is an oxidative 
stress regulator present in the cytoplasm. 
It is inactivated and regulated by binding 
of Kelch-like ECH-associated protein 1 
(Keap 1) for proteasomal degradation 
targets.7–9 Under conditions of oxidative 
stress, Nrf2 becomes separated from the 
complex and translocated to the nucleus, 
to bind to antioxidant-responsive 
elements (ARE), and further induce gene 
expression of endogenous antioxidants 
such as superoxide dismutase, 
glutathione peroxidase and catalase.10 
Decreasing the ratio of Nrf2/Keap1 can 
cause oxidative stress through a decrease 
in endogenous antioxidant enzymes.11 
Catalase is an enzyme that can change 
hydrogen peroxide (H2O2) to become 
water and oxygen, so it is less harmful 
for body components.12
Efforts to suppress the rate 
of oxidative stress are done with 
antioxidants, both endogenous and 
exogenous. Under normal conditions, 
the body will form a balance between 
the formation of free radicals with 
endogenous antioxidants. Frequent 
free radical formation keeps the body 
from maintaining this balance, causing 
cellular damage that results in the 
pathological states of various diseases. 
Therefore, for optimum health benefits, 
it is necessary to add compounds that 
can increase the work of endogenous 
antioxidants.
Currently, many studies have 
demonstrated the role of phytochemical 
compounds such as flavonoids in 
reducing oxidative stress. Flavonoids 
can decrease oxidative stress by reacting 
to free radicals.13 A flavonoid compound 
has been  isolated from mahogany seed 
(Swietenia macrophylla king) by Mursiti14 
and was identified as 7-hydroxy-2-(4-
hydroxy-3-methoxyphenyl)-chromen-
4-one. The aim of this study was to 
investigate the correlations between the 
ratio of Nrf2/Keap1 and catalase gene 
expression in livers of hyperlipidemic 
rats given 7-hydroxy-2-(4-hydroxy-3-
methoxyphenyl)-chromen-4-one.
MATERIALS AND METHODS
Animal 
Twenty-four male rats (Rattus 
norvegicus), 8 weeks old, weigh average 
of 200 g were obtained from the 
Department of Food and Nutrition/PAU 
(Pangan dan Gizi), Universitas Gadjah 
Mada, Yogyakarta, Indonesia. The rats 
were housed in individual cages and 
acclimatized to the laboratory condition 
(22-25oC) and 12 h daylight cycle for 7 
days with free access to food and water 
during the experimental period. The 
standard diet was AIN 93 M consisting of 
(g/kg): Cornstarch (465.692), casein (140), 
dextrinized cornstarch (155), sucrose 
(100), soybean oil (40), alphacel (50), 
AIN-93-MMX (35), L-cysteine 1.8, AIN-93-
VM (10), choline bitartrate (2.5) and ter-
butylhydroquinone (0.008). The present 
study was approved by the Medical and 
Health Research Ethics Committee of 
the Faculty of Medicine, Pubic Health 
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and Nursing, Universitas Gadjah Mada, 
Yogyakarta.
Experimental design 
Twenty-four rats were divided into 6 
groups i.e. Group 1 was normal rats (N), 
Group 2 was hyperlipidemia rats (HL), 
Group 3 was hyperlipidemia rats treated 
with simvastatin 0.18 mg/200gbw (HL+SV), 
and Groups 4-6 were hyperlipidemic rats 
treated with 7--hydroxy-2-(4-hydroxy-
3-methoxyphenyl) -chromen-4-one 
doses 10; 30; or 90 mg/200 g BW day 
(HL+10, HL+30 or HL+90 mg/200 g BW), 
respectively. Hyperlipidemic rats were 
induced by standard AIN 93 with added 
2% pure cholesterol. The compounds 
were administered orally by gavages for 
4 weeks, after which all of the animals 
were euthanized. 
Compound isolation
Compound of 7-hydroxy-2-(4-
hydroxy-3-methoxyphenyl)-chromen-4-
one is a class of flavonoids that derived 
from mahogany seeds (S. macrophylla 
King). This compound was isolated 
by Mursiti.14 The 7-hydroxy-2-(4-
hydroxy-3-methoxyphenyl)-chromen-
4-one was isolated by liquid vacuum 
chromatography and gravity column 
chromatography. Elucidation of 
structural characteristics was carried 
out using IR, UV, and GC spectrometers. 
In this study the dose calculation based 
on our previous study.15  
Gene expression with quantification 
PCR (q-PCR)
cDNA was synthesized using the 
iScript mix Biorad® kit according 
to the protocol of the producer. 
SsoFast™Evagreen® supermix 
Biorad® was used for q-PCR on a 
Biorad iCycler model CFX 96 Real-
Time System. The primers used for 
cDNA amplification were forward 
5’-AACCCCATGACCAACCAGTG- 3’ and 
reverse 5’-CACTCGTCTCGATCTGGCTC-3’ 
for kelch-like ECH-associated protein 
1 (Keap1; 161 bp); forward 5’- 
ATTGCCGTCCGATTCTCC-3’ and reverse 5’- 
CCAGTTACCATCTTCAGTGTAG-3’ for Catalase; 
Forward 5’-GCCTTCCTCTGCTGCCATTAGTC-3’ and 
reverse 5’GTGCCTTCAGTGTGCTTCTGGTT-3’ for 
Nuclear factor erythroid related factor 2 (Nrf-2; 111 
bp), forward 5’-GAATCTCTTCATTCTTGCCATT-3’ 
and reverse 5’-GGCATAGAGGTCTTTACGGATG-3’ 
for beta actin gene (240bp). The q-PCR 
reaction was conducted individually 
with each gene using the same internal 
control beta actin gene. The program for 
cDNA amplification was 5 min at 95 oC, 
followed by 40 cycles at 95 oC for 60 s, 
and 57 oC for 60 s. 
Data analysis 
All results were expressed as mean 
± standard error of mean (SEM). The 
ratio of Nrf2/Keap 1 and catalase gene 
expression between the groups was 
analyzed by One Way ANOVA test. The 
correlations between Nrf2/Keap 1 and 
catalase gene expression were analyzed 
by Spearman test. Data were considered 
statistically significant if p values were 
lower than 0.05.
RESULTS
As shown in FIGURE 1 the ratio 
of Nrf2/Keap 1 in rat livers after the 
administration of the 7-hydroxy-2-(4-
hydroxy-3-methoxyphenyl)-chromen-
4-one doses 30 mg/200 g BW was lower 
than the doses 10 and 90 mg/200 g BW (p 
>0.05).
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FIGURE 2. Catalase gene expression. N, Normal rats; HL, hyperlipidemia rats; 
HL+SV, hyperlipidemia rats + 0.18mg/200 g BW simvastatin; HL+10, 
hyperlipidemia rats + 10mg/200 g BW Flavonoid; HL+ 30, hyperlipidemia 
rats + 30mg/200 g BW; Flavonoid and HL+90, hyperlipidemia rats + 
90mg/200 g BW Flavonoid. N= 24 rats. Data were presented as mean ± 
SEM; p=0.056, according to one way Anova. 
FIGURE 1. Ratio Nrf2/Keap1 gene expression. N, Normal rats; HL, hyperlipidemia 
rats; HL+SV, hyperlipidemia rats +.18mg/200 g BW simvastatin; HL+10, 
hyperlipidemia rats + 10mg/200 g BW Flavonoid; HL+ 30, hyperlipidemia 
rats + 30mg/200 g BW; Flavonoid and HL+90, hyperlipidemia rats + 
90mg/200 g BW Flavonoid. N= 24 rats. Data were presented as mean ± 
SEM;  p=0.400, according to one way Anova. 
The relative expression of catalase 
in rat livers after administration 
of the 7-hydroxy-2-(4-hydroxy-3-
m e t h o x y p h e ny l ) - c h r o m e n - 4 - o n e 
doses 10, 30 and 90 mg/200 g BW for 
four weeks were not significantly 
different (p >0.05) (FIGURE 2).
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Based on Spearman’s analysis to 
determine correlations between ratio of 
Nrf2/Keap1 and catalase gene expression, 
the result showed that no correlation 
between both variables (p > 0.05) and 
ratio alteration does not change the 
catalase relative expression (p >0.05).
DISCUSSION
Reactive oxygen species (ROS) 
are free radicals that can harm body 
components, such as lipid, DNA and 
protein. ROS are produced by normal 
metabolism in the body especially by 
mitochondria metabolism. One of ROS in 
the body is H2O2 that can be more radical 
if it reacts with other metal components 
to become a hydroxyl radical.16 The body 
has antioxidant components to reduce 
increasing ROS by both non-enzymatic 
and enzymatic systems. In the non-
enzymatic system, the body uses NADPH 
and GSH. In the enzymatic system, 
the body uses glutathione peroxidase, 
superoxide dismutase and catalase.16,17 
Catalase is an endogenous enzyme that 
can degrade H2O2 into water and oxygen. 
Its ability is very efficient in degrading 
peroxides but this enzyme needs iron or 
manganese as a cofactor.12,18 Synthesis 
of catalase is regulated by Nrf2 as the 
transcription factor.19
Nuclear factor erythroid 
2-related factor 2 is the most active 
transcriptional regulator in the leucine 
zipper transcription factor family. 
The biological activity Nrf2 is mainly 
exerted through an inhibitory control 
mechanism against Keap1.20 Nuclear 
factor erythroid 2-related factor 2 is a key 
cytokine that regulates the expression 
of antioxidant substances in vivo. The 
normal expression of Nrf2 is critical 
for maintaining oxidant-antioxidant 
balance in the body.21 The Keap1 protein 
contains a number of cysteine residues 
which are sensitive to ROS and modified 
by reactive electrophiles. Under normal 
conditions, Nrf2 is mainly present in 
the cytoplasm and binds to the Keap1 
protein. Oxidation of Keap1 causes 
conformational changes that result in 
release of or inability to bind Nrf2 and 
direct it to proteasomal degradation. 
This condition of increased abundance 
of free Nrf2 protein within the cytosol is 
then translocated to the nucleus where 
it accumulates and binds to AREs which 
transcriptionally regulate expression 
of gene associated with antioxidant 
defense pathways. When the cells are 
exposed to a hyperoxic environment 
the conformation of Keap1 protein is 
changed, the binding to Nrf2 prevented. 
Nrf2 is then released into the nucleus, 
expressed extensively, and promotes the 
expression of downstream antioxidants, 
and resistance to oxidative damage.22
In this study, we determined the 
ratio of Nrf2- keap1 gene expression 
and catalase gene expression. The 
results showed that the highest ratio 
of Nrf2- keap1 was found in rats given 
90mg/200gbw of 7-hydroxy-2-(4-hydroxy-
3-methoxyphenyl)-chromen-4-one and 
the lowest was found in rats treated 
with 0.18mg/200 g BW of simvastatin. 
The ratio of Nrf2- keap1 was decreased 
following stimulation of oxidative 
stress induced by receptor activator of 
nuclear factor-κB ligand (RANKL). The 
flavonoid compounds such as catechin, 
and quercetin, will remove intracellular 
ROS11, through modulation of the Nrf2/
Keap1 pathway.23 According to Habeos 
et al.24 The administration of simvastatin 
did not affect the Nrf2 mRNA levels in rat 
livers. However, in our study we found 
the rats that received simvastatin had the 
lowest Nrf2 gene expression compared 
to all groups (data not shown). 
In this study we also measured the 
correlations between Nrf2/Keap1 ratio 
and catalase gene expression. According 
to Kanzaki et al.,11 Nrf2/Keap1 ratio 
has an association with cytoprotective 
enzyme expression. Decreasing the 
ratio Nrf2/Keap1 will be attenuating 
the cytoprotective enzyme expression. 
29
J Med Sci, Volume 51, Number 1, January 2019: 24-30 
However, our study showed that there 
was no correlation between Nrf2/Keap1 
ratio and catalase gene expression. 
CONCLUSION
In conclusion, administration 
of  7-hydroxy-2-(4-hydroxy-3-
m e t h o x y p h e ny l ) - c h r o m e n - 4 - o n e 
compound can improve catalase gene 
expression in hyperlipidemic rats. 
However, there is no correlation between 
ratio of the Nrf2/Keap1 gene expression 
and the catalase gene expression.
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